Masahiro Tabata

The Relationship between Epidermal Growth Factor Receptor Mutations and Clinicopathologic Features in Non–Small Cell Lung Cancers

Masaki Tokumo, Shinichi Toyooka, Katsuyuki Kiura et al. · Clinical Cancer Research · 2005 · 496 citations · Full text

Medicine, Genetics, Oncology +15

Phase III Trial Comparing Docetaxel and Cisplatin Combination Chemotherapy With Mitomycin, Vindesine, and Cisplatin Combination Chemotherapy With Concurrent Thoracic Radiotherapy in Locally Advanced Non–Small-Cell Lung Cancer: OLCSG 0007

Yoshihiko Segawa, Katsuyuki Kiura, Nagio Takigawa et al. · Journal of Clinical Oncology · 2010 · 255 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Identification of Epigenetic Aberrant Promoter Methylation in Serum DNA Is Useful for Early Detection of Lung Cancer

Keiichi Fujiwara, Nobukazu Fujimoto, Masahiro Tabata et al. · Clinical Cancer Research · 2005 · 202 citations · Full text

Medicine, Molecular Biology, Oncology +17

Effect of gefitinib (‘Iressa’, ZD1839) on brain metastases in patients with advanced non-small-cell lung cancer

Katsuyuki Hotta, Katsuyuki Kiura, Hiroshi Ueoka et al. · Lung Cancer · 2004 · 178 citations

Medicine, Neurology, Oncology +13

Complementary roles of pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in diagnosis and prognosis of small-cell lung cancer (SCLC)

Takuo Shibayama, Hiroshi Ueoka, Kenji Nishii et al. · Lung Cancer · 2001 · 151 citations

Medicine, Molecular Medicine, Oncology +6